The forecast for malignant neoplasms mortality in the UK among women shows a slight, gradual decline from 2024 to 2028, dropping from 229.9 to 228.8 deaths per hundred thousand. This represents an overall year-on-year percentage decrease across the given period. The data highlights a downward trajectory compared to 2023, when the mortality rate stood higher. The Compound Annual Growth Rate (CAGR) over these five years is negative, indicating consistent reductions each year in female mortality rates from this cause.
Future trends to watch for include advancements in medical treatments and early detection technologies, which could further reduce mortality rates. Additionally, lifestyle changes and public health interventions may contribute to accelerated declines in the long-term.
